• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Informing patients about tardive dyskinesia. Controlled trial of patient education.

作者信息

Chaplin R, Kent A

机构信息

Pathfinder Mental Health Service, London.

出版信息

Br J Psychiatry. 1998 Jan;172:78-81. doi: 10.1192/bjp.172.1.78.

DOI:10.1192/bjp.172.1.78
PMID:9534837
Abstract

BACKGROUND

This paper evaluates the effects on knowledge and clinical stability of an educational intervention about tardive dyskinesia.

METHOD

Fifty-six patients receiving antipsychotic maintenance completed a questionnaire assessing their knowledge about tardive dyskinesia. After random allocation to either an educational intervention or a control group, their knowledge was reassessed at six months.

RESULTS

Ninety-five per cent of patients completed the study. The study patients gained significantly more knowledge than the controls, who made modest gains. There were no significant differences in clinical outcome between the groups.

CONCLUSION

Patients can learn about serious toxic effects of antipsychotic treatment with a low risk of non-compliance. Discussion about tardive dyskinesia is necessary in the process of obtaining informed consent to treatment.

摘要

相似文献

1
Informing patients about tardive dyskinesia. Controlled trial of patient education.
Br J Psychiatry. 1998 Jan;172:78-81. doi: 10.1192/bjp.172.1.78.
2
Informing patients about tardive dyskinesia: four-year follow up of a trial of patient education.
Aust N Z J Psychiatry. 2002 Feb;36(1):99-103. doi: 10.1046/j.1440-1614.2002.00979.x.
3
Informed consent and tardive dyskinesia.知情同意与迟发性运动障碍
Am J Psychiatry. 1989 Jul;146(7):902-4. doi: 10.1176/ajp.146.7.902.
4
Tardive dyskinesia, impaired recall, and informed consent.迟发性运动障碍、记忆受损与知情同意。
J Clin Psychiatry. 1985 Oct;46(10):434-5.
5
KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia.KINECT 3 试验:坎非丁治疗迟发性运动障碍的 3 期随机、双盲、安慰剂对照试验
Am J Psychiatry. 2017 May 1;174(5):476-484. doi: 10.1176/appi.ajp.2017.16091037. Epub 2017 Mar 21.
6
Prevention and management of tardive dyskinesia.迟发性运动障碍的预防与管理。
J Clin Psychiatry. 1985 Apr;46(4 Pt 2):14-8.
7
Informing patients about tardive dyskinesia.向患者告知迟发性运动障碍。
Arch Gen Psychiatry. 1985 Sep;42(9):866-71. doi: 10.1001/archpsyc.1985.01790320034005.
8
Relationship of awareness of dyskinesia in schizophrenia to insight into mental illness.精神分裂症中运动障碍意识与对精神疾病洞察力的关系。
Am J Psychiatry. 1999 Jul;156(7):1097-9. doi: 10.1176/ajp.156.7.1097.
9
Effects of antipsychotic treatment on tardive dyskinesia: a 6-month evaluation of patients from the European Schizophrenia Outpatient Health Outcomes (SOHO) Study.抗精神病药物治疗对迟发性运动障碍的影响:来自欧洲精神分裂症门诊健康结局(SOHO)研究的患者为期6个月的评估。
J Clin Psychiatry. 2005 Sep;66(9):1130-3.
10
Informed consent and tardive dyskinesia. Long-term follow-up.知情同意与迟发性运动障碍。长期随访。
J Nerv Ment Dis. 1996 Sep;184(9):517-22. doi: 10.1097/00005053-199609000-00001.

引用本文的文献

1
Potential negative impact of informing patients about medication side effects: a systematic review.告知患者药物副作用的潜在负面影响:一项系统评价
Int J Clin Pharm. 2018 Aug;40(4):806-822. doi: 10.1007/s11096-018-0716-7. Epub 2018 Aug 23.
2
Miscellaneous treatments for antipsychotic-induced tardive dyskinesia.抗精神病药物所致迟发性运动障碍的其他治疗方法。
Cochrane Database Syst Rev. 2018 Mar 19;3(3):CD000208. doi: 10.1002/14651858.CD000208.pub2.
3
Interventions for enhancing medication adherence.提高药物依从性的干预措施。
Cochrane Database Syst Rev. 2014 Nov 20;2014(11):CD000011. doi: 10.1002/14651858.CD000011.pub4.
4
Psychoeducation for schizophrenia.精神分裂症的心理教育
Cochrane Database Syst Rev. 2011 Jun 15;2011(6):CD002831. doi: 10.1002/14651858.CD002831.pub2.
5
Frequency and effects of psychosocial interventions additional to olanzapine treatment in routine care of schizophrenic patients.在精神分裂症患者的常规护理中,除奥氮平治疗外的心理社会干预措施的频率及效果
Soc Psychiatry Psychiatr Epidemiol. 2008 May;43(5):373-9. doi: 10.1007/s00127-008-0318-0.
6
The impact of informing psychiatric patients about their medication: a systematic review.告知精神科患者其所用药物的影响:一项系统综述
Pharm World Sci. 2006 Dec;28(6):329-41. doi: 10.1007/s11096-006-9054-2. Epub 2007 Jan 10.
7
[Patient knowledge regarding tardive dyskinesia].[患者关于迟发性运动障碍的知识]
Nervenarzt. 2006 Mar;77(3):333-7. doi: 10.1007/s00115-005-1897-6.
8
Enhancing patient satisfaction and increasing treatment compliance: patient education as a fundamental component of PTSD treatment.
Psychiatr Q. 2004 Winter;75(4):321-32. doi: 10.1023/b:psaq.0000043508.52428.6e.
9
The risks of multimedia methods: effects of actor's race and gender on preferences for health states.多媒体方法的风险:演员的种族和性别对健康状态偏好的影响。
J Am Med Inform Assoc. 2000 Mar-Apr;7(2):177-85. doi: 10.1136/jamia.2000.0070177.
10
Patient-oriented strategies for the prevention of drug interactions.以患者为导向的药物相互作用预防策略。
Drug Saf. 2000 Feb;22(2):103-9. doi: 10.2165/00002018-200022020-00003.